SCHEMBL5843155

SCHEMBL5843155

Cc1ccc(Cl)c(-c2ccc(N)c(O)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.52
CYP3A4 P08684 4/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 5/20 0.44
ESR2 Q92731 1/20 0.40
TDP1 Q9NUW8 4/20 0.39
TP53 P04637 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
THRB P10828 1/20 0.39
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
ALKBH3 Q96Q83 1/20 0.39
TSHR P16473 2/20 0.37
MAPK1 P28482 1/20 0.37
AHR P35869 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845279 0.87 ALOX15 (0.52) ALOX15CYP3A4HSD17B10ALDH1A1ESR2
SCHEMBL18203013 0.84 TDP1 (0.54) ALOX15CYP3A4HSD17B10ALDH1A1ESR2
SCHEMBL5843853 0.83 CYP3A4 (0.55) ALOX15CYP3A4HSD17B10ALDH1A1ESR2
SCHEMBL5842729 0.83 ALOX15 (0.55) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL5843781 0.80 CYP3A4 (0.52) ALOX15CYP3A4HSD17B10ALDH1A1ESR2
SCHEMBL5843762 0.80 ALOX15 (0.52) ALOX15CYP3A4HSD17B10ALDH1A1ESR2
SCHEMBL21021367 0.79 ALDH1A1 (0.55) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL5845352 0.79 ALOX15 (0.55) ALOX15CYP3A4HSD17B10ALDH1A1ESR2
SCHEMBL6376797 0.79 ALOX15 (0.37) ALOX15CYP3A4HSD17B10ALDH1A1TDP1
SCHEMBL5845416 0.77 CYP3A4 (0.63) ALOX15CYP3A4HSD17B10ALDH1A1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US claimed
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US disclosed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP disclosed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US disclosed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives KRT18, CBR3, CCNB3 ALOX15 3006/4885CYP3A4 835/4885HSD17B10 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.